Using cardiac magnetic resonance (CMR) imaging to guide TAVI cases is noninferior to the more common approach of preprocedural computed tomography with regard to device implantation success, according ...

ANDOVER, Mass., Aug. 21, 2014 /PRNewswire/ -- Royal Philips today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for ...

Royal Philips (NYSE: PHG AEX: PHIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter ...

Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguide TM ...

Fewer than one in 50 TAVI patients undergo reintervention within 8 years, with most of the repeat procedures done early and using redo TAVI, according to French registry data spanning from 2010 to ...

Aortic stenosis (AS) is the most common acquired valvular heart disease in adults worldwide, particularly affecting individuals over 75 years of age. It is characterized by rapidly progressive ...

Aortic stenosis is a serious heart valve condition characterized by narrowing and stiffening of the aortic valve, restricting blood flow from the heart to the body. This forces the heart to work ...

Royal Philips, a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of healthcare, consumer lifestyle and lighting, has received ...